Medecins Sans Frontieres wants the Trans-Pacific Partnership to amend terms

16 July 2013

Worldwide humanitarian organization Medecins Sans Frontieres (MSF) is urging the countries participating in the Trans-Pacific Partnership (TPP) agreement in Malaysia this week to consider the need for affordable medicines.

MSF wants negotiating countries to remove terms that could block people from accessing affordable medicines, slow production of generic medicines and constrain the ability of governments to pass laws in the interest of public health.

Fifa Rahman, of the Malaysian AIDS Council, said: “Just prior to hosting an international AIDS conference two weeks ago, the Malaysian government made an important pledge to reject harmful provisions in the TPP trade deal that will increase medicine prices for Malaysians, who already pay some of the highest prices for HIV drugs among developing countries. We need all negotiating countries to not only make the same strong public pledge to protect public health, but also to ensure that the technical details of the deal truly fulfill their principled commitments to global public health.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Generics